IRIS
PEPE, MARTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.343
AS - Asia 2.494
EU - Europa 2.391
SA - Sud America 573
Continente sconosciuto - Info sul continente non disponibili 463
AF - Africa 126
OC - Oceania 8
AN - Antartide 1
Totale 13.399
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.128
SG - Singapore 1.030
IT - Italia 1.022
CN - Cina 446
BR - Brasile 432
DE - Germania 346
HK - Hong Kong 289
RU - Federazione Russa 224
FR - Francia 209
VN - Vietnam 178
FI - Finlandia 169
BD - Bangladesh 152
GB - Regno Unito 123
CA - Canada 110
SE - Svezia 101
IN - India 79
AR - Argentina 58
ID - Indonesia 51
NL - Olanda 42
IQ - Iraq 38
PK - Pakistan 37
CI - Costa d'Avorio 34
TR - Turchia 34
MX - Messico 30
JP - Giappone 26
CO - Colombia 24
ZA - Sudafrica 23
AT - Austria 21
EC - Ecuador 19
PH - Filippine 18
ES - Italia 17
TN - Tunisia 17
UA - Ucraina 16
BE - Belgio 15
MA - Marocco 15
PL - Polonia 15
UZ - Uzbekistan 15
VE - Venezuela 15
MY - Malesia 14
CR - Costa Rica 12
SA - Arabia Saudita 12
JO - Giordania 11
CZ - Repubblica Ceca 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
IE - Irlanda 9
JM - Giamaica 9
AU - Australia 8
GT - Guatemala 8
NI - Nicaragua 8
PE - Perù 8
AZ - Azerbaigian 7
CH - Svizzera 7
EG - Egitto 7
PY - Paraguay 7
CL - Cile 6
IL - Israele 6
KE - Kenya 6
TT - Trinidad e Tobago 6
BB - Barbados 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KZ - Kazakistan 5
SV - El Salvador 5
DK - Danimarca 4
EE - Estonia 4
GP - Guadalupe 4
IR - Iran 4
TH - Thailandia 4
BG - Bulgaria 3
DZ - Algeria 3
ET - Etiopia 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
QA - Qatar 3
SC - Seychelles 3
TW - Taiwan 3
AL - Albania 2
AM - Armenia 2
BF - Burkina Faso 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AO - Angola 1
AQ - Antartide 1
Totale 12.912
Salva come PNG Salva come JPEG
Città #
Dallas 2.648
Ashburn 599
San Jose 583
Singapore 550
Milan 294
Hong Kong 284
Fairfield 223
Council Bluffs 210
Beijing 167
Munich 161
Helsinki 134
Chandler 133
New York 123
Woodbridge 121
Houston 104
Boardman 103
Rome 103
Columbus 95
Los Angeles 94
Lauterbourg 90
Santa Clara 85
Bari 82
Seattle 82
Falkenstein 81
Cambridge 76
Nyköping 65
Wilmington 62
Buffalo 55
Ho Chi Minh City 52
Phoenix 50
Ann Arbor 47
Hanoi 45
Jakarta 43
São Paulo 38
Chicago 37
Abidjan 34
Marseille 34
Naples 32
Montreal 28
London 23
Turin 23
Xi'an 23
Frankfurt am Main 22
Toronto 22
Nuremberg 21
Tokyo 21
Turku 20
Baghdad 19
Brooklyn 19
Lawrence 19
Roxbury 19
Atlanta 18
Figino 18
Jacksonville 18
North Bergen 17
Rio de Janeiro 17
Denver 16
Nanjing 16
Poplar 15
San Diego 15
Tashkent 15
Moscow 14
Florence 13
Manchester 13
San Francisco 13
Shenzhen 13
Brussels 12
Da Nang 12
Johannesburg 12
Stockholm 12
Ankara 11
Des Moines 11
Karachi 11
Lahore 11
Mexico City 11
Salt Lake City 11
Salvador 11
Secaucus 11
The Dalles 11
Amman 10
Barletta 10
Bogotá 10
Charlotte 10
Miami 10
Orem 10
Bologna 9
Paris 9
San José 9
Warsaw 9
Washington 9
Brasília 8
Buenos Aires 8
Chennai 8
Curitiba 8
Dong Ket 8
Dublin 8
Foggia 8
Haiphong 8
Vienna 8
Belo Horizonte 7
Totale 8.660
Salva come PNG Salva come JPEG
Nome #
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 438
Sailing Across Contraception, Pregnancy, and Breastfeeding: The Complex Journey of Women with Cardiomyopathies 327
A novel multidisciplinary approach in an LMNA-mutated patient: the importance of considering the overall clinical picture for the early diagnosis 304
Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation 275
Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X 258
Giant Cardiac Fibroma in a Completely Asymptomatic Teenager 250
No Reflow-phenomenon: from Current State of the Art to Future Perspectives 243
Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome 241
Impact of Predilation Before Transcatheter Aortic Valve Implantation with New-Generation Devices 236
A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient 227
Emergency coronary and peripheral arteries combined with percutaneous intervention in the elderly: success or therapeutic excess? 219
Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation 217
Prime time for the sweet spot in timing of coronary invasive approach in patients with non-ST elevation myocardial infarction 210
Remote ischemic preconditioning in isolated valve intervention. A pooled meta-analysis 204
How to Approach a Spontaneous Coronary Artery Dissection: An Up-To-Date 203
Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents 203
Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction 200
Omega-3 fatty acids for the prevention of myocardial infarction and arrhythmias 197
Cardiogenic Shock following Acute Myocardial Infarction: What's New? 195
Reverse takotsubo cardiomyopathy followed by left ventricle outflow tract obstruction: A dangerous relay race 194
'Broken-heart' syndrome: ventricular septal perforation in a takotsubo cardiomyopathy 193
Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction 186
Life-threatening acute myocardial infarction due to left main dissection during radiofrequency transcatheter ablation of atrial tachycardia 186
STEMI and NSTEMI ACS in a 30-Year-Old Patient: An Extremely Rare Complication of a Left Atrial Myxoma. 182
Role of plasma glucose level on myocardial perfusion in ST-segment elevation myocardial infarction patients 177
Correlation between endothelial dysfunction and myocardial damage in acute phase of Tako-Tsubo cardiomyopathy: brachial flow mediated dilation as a potential marker for assessment of patient with Tako-Tsubo. 173
Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk 173
Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy 163
Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure 148
Antithrombotic Therapy for Vascular Disease and Intervention: The Best Is Yet to Come? 142
Importance of clinical suspicion and multidisciplinary management for early diagnosis of a cardiac laminopathy patient: A case report 141
Aortic coarctation: guidelines mismatch across the ocean 138
Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X 136
Th2-dependent cytokine release in patients treated with coronary angioplasty 131
Aortic valve fibroelastoma presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA): a case report and review of the literature 129
Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience 129
Infiammazione Th17 dipendente e attivazione metallo-proteasica dopo angioplastica coronarica. 127
Assessing the Best Prognostic Score for Transcatheter Aortic Valve Implantation (from the RISPEVA Registry) 125
Inflammatory bowel disease and acute coronary syndromes: From pathogenesis to the fine line between bleeding and ischemic risk. 123
Fractional flow reserve and intravascular scan as part of the coronary fistulas diagnostic process: Future perspectives 120
Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis? 116
Sudden cardiac death secondary to demonstrated reperfusion ventricular fibrillation in a woman with Takotsubo cardiomyopathy 116
Prognostic value of 12-leads admission electrocardiogram in low-risk patients hospitalized for COVID-19 114
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 111
Alex Plus Versus Xience Drug-Eluting Stents for Percutaneous Coronary Intervention in Routine Clinical Practice: A Propensity Score-Matched Analysis 111
A Young Patient Presenting with Dilated Cardiomyopathy and Renal Infarction during Treatment with Isotretinoin: Mere Coincidence or Serious Side Effect of a Drug Commonly Used in Adolescence? 111
TAVI-CT score to evaluate the anatomic risk in patients undergoing transcatheter aortic valve implantation 110
Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry 109
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies 108
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]) 108
Percutaneous exclusion of ascending aorta pseudoaneurysms: still an interventional challenge? 107
Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients ≥85 Years Versus Those <85 Years 105
Corrigendum to "A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient" 104
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 104
Baseline, procedural and outcome features of patients undergoing transcatheter aortic valve implantation according to different body mass index categories 102
A concealed case of takotsubo syndrome as consequence of ab ingestis episode in a revascularized patient 98
Degenerative Severe Aortic Stenosis and Concomitant Coronary Artery Disease: What Is Changing in the Era of the "Transcatheter Revolution"? 91
MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient 88
Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease: A Propensity Score-Adjusted Analysis From the RISPEVA Registry 86
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 86
Transcatheter aortic valve implantation with Allegra: procedural and mid-term outcomes according to experience phase in a high-volume center 86
COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). 81
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19 81
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart 80
Anti-Inflammatory Therapy for Acute Coronary Syndromes: Is It Time for a Shift in the Treatment Paradigm? 80
Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Who Underwent Percutaneous Coronary Interventions 80
Percutaneous Edge-to-Edge Transcatheter Mitral Valve Repair: Current Indications and Future Perspectives. 80
Clinical use of cangrelor: a real-world multicenter experience from South Italy 79
Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study 77
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry 77
Transcatheter aortic valve implantation in patients with age ≤70 years: experience from two leading structural heart disease centers 76
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases 74
Minimally invasive approaches to primary cardiac tumors: A systematic review and meta-analysis 73
Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes 73
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry 72
Role of pre-operative embolization in carotid body tumor surgery according to Shamblin classification: A systematic review and meta-analysis 71
Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway 70
Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study 69
Impact of Tirofiban on Serum Troponin Changes in Patients Undergoing Carotid Artery Stenting: A Propensity Matched Analysis 68
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections 68
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19 67
Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation 67
Acute Hyperglycemia-Induced Injury in Myocardial Infarction 66
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis 63
Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score 63
Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry) 63
Long-Term Follow-Up of Transcatheter Aortic Valve Implantation With Portico Versus Evolut Devices 61
The best way to transcatheter aortic valve implantation: from standard to new approaches 61
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 61
Thrombocytopenia Complicating Transcatheter Aortic Valve Implantation: Differences Between Two New-Generation Devices 60
Role of Indobufen in Coronary Artery Disease: The Story of a Neglected Drug. A Systematic Review 58
Incidence and Predictors of Cerebrovascular Accidents in Patients Who Underwent Transcatheter Mitral Valve Repair With MitraClip 57
Unsupervised Machine Learning with Cluster Analysis in Patients Discharged after an Acute Coronary Syndrome: Insights from a 23,270-Patient Study 57
Underlying heart diseases and acute COVID-19 outcomes 57
Percutaneous axillary vs femoral access for transcatheter aortic valve replacement: Insights from a 2164-patient study 55
Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis 55
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry 55
Impact of coronary artery disease on outcome after transcatheter edge-to-edge mitral valve repair with the MitraClip system 54
Impact of Institutional Monthly Volume of Transcatheter Edge-to-Edge Repair Procedures for Significant Mitral Regurgitation: Evidence from the GIOTTO-VAT Study 54
Appraising features and outlook of women and men discharged after an acute coronary syndrome: evidence from the 23,700-patient PRAISE International Registry 54
Totale 12.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022164 0 0 0 4 10 26 16 11 14 18 25 40
2022/2023471 32 44 21 22 31 45 2 54 86 76 39 19
2023/2024319 21 50 22 26 35 80 8 13 10 12 9 33
2024/20251.925 93 20 80 130 78 148 289 176 98 107 221 485
2025/20267.790 514 224 3.014 469 475 291 547 210 641 542 192 671
2026/20271.645 438 263 295 649 0 0 0 0 0 0 0 0
Totale 13.399